A new trading day began on Tuesday, with Century Therapeutics Inc (NASDAQ: IPSC) stock price up 8.85% from the previous day of trading, before settling in for the closing price of $0.57. IPSC’s price has ranged from $0.34 to $1.25 over the past 52 weeks.
It was noted that within the last five years, the titan of the Healthcare sector saw sales topped by 18.46%. Meanwhile, its annual earnings per share averaged 91.72%. With a float of $45.91 million, this company’s outstanding shares have now reached $86.53 million.
Century Therapeutics Inc (IPSC) Insider and Institutional Ownership
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Century Therapeutics Inc is 47.47%, while institutional ownership is 22.77%. The most recent insider transaction that took place on Dec 12 ’25, was worth 30,352. In this transaction President and CEO of this company bought 52,000 shares at a rate of $0.58, taking the stock ownership to the 3,322,990 shares. Before that another transaction happened on Dec 08 ’25, when Company’s SVP Finance & Operations sold 257 for $0.53, making the entire transaction worth $137. This insider now owns 404,874 shares in total.
Century Therapeutics Inc (IPSC) Latest Financial update
In its latest quarterly report, released on 12/31/2024, the company reported earnings of -0.35 per share, which was $0.1 higher than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.3 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 91.72% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 20.63% during the next five years compared to 18.46% growth over the previous five years of trading.
Century Therapeutics Inc (NASDAQ: IPSC) Trading Performance Indicators
Here are Century Therapeutics Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 6.25. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 0.48.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.31, a number that is poised to hit -0.27 in the next quarter and is forecasted to reach -0.85 in one year’s time.
Technical Analysis of Century Therapeutics Inc (IPSC)
The latest stats from [Century Therapeutics Inc, IPSC] show that its last 5-days average volume of 0.82 million was superior to 0.79 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 67.61%.
During the past 100 days, Century Therapeutics Inc’s (IPSC) raw stochastic average was set at 74.32%, which indicates a significant decrease from 95.74% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.0379 in the past 14 days, which was higher than the 0.0374 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.5537, while its 200-day Moving Average is $0.5457. Now, the first resistance to watch is $0.6456. This is followed by the second major resistance level at $0.6688. The third major resistance level sits at $0.7096. If the price goes on to break the first support level at $0.5816, it is likely to go to the next support level at $0.5408. The third support level lies at $0.5176 if the price breaches the second support level.
Century Therapeutics Inc (NASDAQ: IPSC) Key Stats
With a market capitalization of 54.41 million, the company has a total of 87,405K Shares Outstanding. Currently, annual sales are 6,590 K while annual income is -126,570 K. The company’s previous quarter sales were 0 K while its latest quarter income was -32,540 K.
